Eli Lilly is the world's most valuable drug company, partially known for blockbuster anti-obesity drugs that are transforming America. In an episode of "The David Rubenstein Show: Peer to Peer Conversations," CEO Dave Ricks talks about how GLP-1 anti-obesity medications work and Lilly's plans to develop a pill. Ricks also discusses the side effects that come from taking these drugs. This interview was recorded on December 10 at the Economic Club of Washington DC. (Source: Bloomberg)
